Results 151 to 160 of about 692,682 (292)
Switching from biosimilar (Basalin) to originator (Lantus) insulin glargine is effective in Chinese patients with diabetes mellitus: a retrospective chart review [PDF]
, 2018 Xia Hu +5 more
openalex +1 more source
Exploring Stakeholder Perceptions and Experience of Biosimilar Insulin Switching: A Scoping Review
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.This scoping review has systematically mapped the existing literature on stakeholder perceptions and experience of biosimilar insulin switches. It shows that there is a lack of high‐quality context‐specific research in this area, and more needs to be done to understand this topic. ABSTRACT Background The option to switch patients to more cost‐effective
Ben Hindley +4 more
wiley +1 more source
Acta Biomedica Scientifica, 2019 Aims: adaptation and validation of the ELISA method insulin glargine determination for the pharmacokinetic study, practical approval in the biosimilars clinical trial.Materials and methods.
L. N. Shitov +9 more
doaj +1 more source
Endocrinology, Diabetes &Metabolism, Volume 9, Issue 1, January 2026.Integrated framework for tirzepatide in HFpEF management. Through metabolic, haemodynamic, structural and anti‐inflammatory pathways, tirzepatide modifies the disease trajectory of HFpEF, leading to improvements in symptoms, functional capacity and reduction in HF events.
Hamza A. Abdul‐Hafez +9 more
wiley +1 more source
Journal of Diabetes Research, 2018 To achieve good metabolic control in diabetes and maintain it in the long term, a combination of changes in lifestyle and pharmacological treatment is necessary.
Hernando Vargas-Uricoechea
doaj +1 more source
Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer [PDF]
, 2020 Inmaculada Hernandez, Walid F. Gellad
openalex +1 more source
Recent Developments in Capillary and Microchip Electroseparations of Peptides (2023–mid 2025)
ELECTROPHORESIS, Volume 47, Issue 1, Page 106-136, January 2026.ABSTRACT This review presents a comprehensive overview of the developments and applications of high‐performance capillary and microchip electromigration methods (zone electrophoresis in a free solution or in sieving media, isotachophoresis, isoelectric focusing, affinity electrophoresis, electrokinetic chromatography, and electrochromatography) for ...
Václav Kašička
wiley +1 more source
Journal of General and Family Medicine, Volume 27, Issue 1, January 2026.ABSTRACT We report an 80‐year‐old man with type 2 diabetes who presented with life‐threatening hypoglycemia (36 mg/dL) and coma, requiring high‐dose insulin (74 units/day). Exogenous insulin antibody syndrome (EIAS) was suspected due to his glycemic instability and high insulin requirements. Subsequent testing confirmed elevated insulin antibodies (8.7
Kazuki Miyaue, Hiroki Isono
wiley +1 more source
Long-term insulin glargine therapy in type 2 diabetes mellitus: a focus on cardiovascular outcomes
Vascular Health and Risk Management, 2015 Joshua J Joseph, Thomas W Donner Division of Endocrinology, Diabetes and Metabolism, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA Abstract: Cardiovascular disease is the leading cause of mortality in type 2 ...
Joseph JJ, Donner TW
doaj